Strategic partnerships are becoming a vital component of success within the Hyperammonemia Treatment Market. Companies are increasingly collaborating to pool expertise, share research costs, and expedite the clinical trial process. These alliances are particularly important in the rare disease space, where resource management and specialized knowledge are paramount to successfully navigating...